Skip to main content
Figure 2 | Diabetology & Metabolic Syndrome

Figure 2

From: Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease

Figure 2

Associations of the remnant lipoprotein cholesterol level with the levels of triglycerides, low-density lipoprotein (LDL) cholesterol, and malondialdehyde-modified LDL (MDA-LDL). A and B, The remnant lipoprotein cholesterol level (mg/dL) was significantly correlated with the levels of triglycerides (mg/dL) (A) and LDL cholesterol (mg/dL) (B) with the indicated correlation coefficient (r) and p value in simple regression analyses. C, The remnant lipoprotein cholesterol level (mg/dL) was significantly correlated with the MDA-LDL level (U/L) with the indicated partial correlation coefficient (β) and p value in a multiple regression model adjusted for LDL cholesterol level.

Back to article page